SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-031911
Filing Date
2016-10-18
Accepted
2016-10-18 19:45:41
Documents
2
Period of Report
2016-10-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4363
2 EX-24 DOCUMENT attachment1.htm EX-24 4458
  Complete submission text file 0000899243-16-031911.txt   11007
Mailing Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368
Business Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368 492143081933
BAYER AKTIENGESELLSCHAFT (Reporting) CIK: 0001144145 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 161941689
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139 617-315-4600
Bayer Global Investments B.V. (Reporting) CIK: 0001685417 (see all company filings)

State of Incorp.: XX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 161941690